Ipsen

Ipsen is a French specialty biopharmaceutical company with one of three global hubs based in the UK.

Its Wrexham site serves as the company's global neuroscience centre of excellence, responsible for research, development and manufacture of neurotoxin products including botulinum toxin. The London site houses commercial, R&D and corporate functions spanning both UK and international operations.

Ipsen's UK portfolio spans oncology, rare diseases and neuroscience, with over 850 employees across both sites.